First Manhattan’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-63
Closed -$6K 1337
2019
Q2
$6K Hold
63
﹤0.01% 1218
2019
Q1
$6K Buy
+63
New +$5.62K ﹤0.01% 1243
2017
Q4
Sell
-150
Closed -$14K 1451
2017
Q3
$14K Hold
150
﹤0.01% 1172
2017
Q2
$13K Hold
150
﹤0.01% 1138
2017
Q1
$13K Hold
150
﹤0.01% 1154
2016
Q4
$12K Hold
150
﹤0.01% 1142
2016
Q3
$13K Hold
150
﹤0.01% 1148
2016
Q2
$15K Hold
150
﹤0.01% 1154
2016
Q1
$15K Hold
150
﹤0.01% 1100
2015
Q4
$13K Hold
150
﹤0.01% 1140
2015
Q3
$13K Hold
150
﹤0.01% 1141
2015
Q2
$15K Hold
150
﹤0.01% 1141
2015
Q1
$13K Hold
150
﹤0.01% 1168
2014
Q4
$13K Hold
150
﹤0.01% 1190
2014
Q3
$11K Hold
150
﹤0.01% 1188
2014
Q2
$10K Hold
150
﹤0.01% 1191
2014
Q1
$11K Hold
150
﹤0.01% 1173
2013
Q4
$10K Hold
150
﹤0.01% 1165
2013
Q3
$11K Hold
150
﹤0.01% 1147
2013
Q2
$10K Buy
+150
New +$10.1K ﹤0.01% 1154

Other funds holding CRI

First Manhattan's CRI Position: Q3 2019 in Review

First Manhattan sold out of Carter's (CRI) in Q3 2019, closing a stake of 63 shares — an estimated $6K sold.

First Manhattan first reported a position in CRI in Q2 2013 and held it in 20 quarters. The position peaked at $15K in Q2 2016. 285 funds tracked by Wall St. Rank hold CRI as of Q3 2019.

  • First Manhattan reported no remaining Carter's position as of Q3 2019 after selling out during the quarter.
  • First Manhattan sold 63 Carter's shares in Q3 2019, an estimated $6K.
  • First Manhattan first reported a position in Carter's in Q2 2013 and held it in 20 quarters.
  • First Manhattan's Carter's position peaked at $15K in Q2 2016.
  • 285 funds tracked by Wall St. Rank held Carter's as of Q3 2019.

Based on First Manhattan's 13F filing for Q3 2019, filed 13 Nov 2019.